KRYS – Krystal Biotech, Inc.
Krystal Biotech, Inc.KRYS
$134.94Name : Krystal Biotech, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $3,905,568,512.00
EPSttm : 3.59
Krystal Biotech, Inc.
$134.94
14.04%$22.04Float Short %
12.66
Margin Of Safety %
51
Put/Call OI Ratio
1.59
EPS Next Q Diff
0.36
EPS Last/This Y
3.11
EPS This/Next Y
3.16
Price
134.94
Target Price
207.36
Analyst Recom
1.17
Performance Q
-18.79
Relative Volume
5.68
Beta
0.66
Ticker: KRYS
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-07 | KRYS | 139.72 | 1.27 | 9.21 | 10541 |
| 2025-07-08 | KRYS | 143.34 | 1.29 | 0.13 | 10661 |
| 2025-07-09 | KRYS | 149.06 | 1.28 | 4.63 | 10683 |
| 2025-07-10 | KRYS | 150.74 | 1.28 | 0.10 | 10681 |
| 2025-07-11 | KRYS | 148.25 | 1.28 | 0.01 | 10703 |
| 2025-07-14 | KRYS | 150.28 | 1.28 | 0.04 | 10714 |
| 2025-07-15 | KRYS | 147.87 | 1.25 | 1.04 | 10830 |
| 2025-07-16 | KRYS | 149.97 | 1.25 | 0.12 | 10898 |
| 2025-07-17 | KRYS | 150 | 1.25 | 0.07 | 10920 |
| 2025-07-18 | KRYS | 147.52 | 1.29 | 0.42 | 11107 |
| 2025-07-21 | KRYS | 148.16 | 1.45 | 30.91 | 11736 |
| 2025-07-22 | KRYS | 151.9 | 1.65 | 0.33 | 12782 |
| 2025-07-23 | KRYS | 153.22 | 1.64 | 0.60 | 12796 |
| 2025-07-24 | KRYS | 150.54 | 1.64 | 0.33 | 12788 |
| 2025-07-25 | KRYS | 147.7 | 1.64 | 0.10 | 12789 |
| 2025-07-28 | KRYS | 152.91 | 1.63 | 1.64 | 12827 |
| 2025-07-29 | KRYS | 152.11 | 1.64 | 0.20 | 12960 |
| 2025-07-30 | KRYS | 153.15 | 1.64 | 9.50 | 12982 |
| 2025-07-31 | KRYS | 153.92 | 1.65 | 0.19 | 13011 |
| 2025-08-01 | KRYS | 156.92 | 1.64 | 0.32 | 13025 |
| 2025-08-04 | KRYS | 134.88 | 1.59 | 0.39 | 13234 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-07 | KRYS | 139.76 | 35.2 | 30.3 | 5.88 |
| 2025-07-08 | KRYS | 143.34 | 35.2 | 40.0 | 5.88 |
| 2025-07-09 | KRYS | 148.90 | 35.2 | 42.6 | 5.88 |
| 2025-07-10 | KRYS | 149.74 | 35.2 | 36.1 | 5.88 |
| 2025-07-11 | KRYS | 148.17 | 35.2 | 34.0 | 5.88 |
| 2025-07-14 | KRYS | 150.41 | 35.2 | 37.9 | 5.88 |
| 2025-07-15 | KRYS | 147.73 | 35.2 | 31.4 | 5.88 |
| 2025-07-16 | KRYS | 149.97 | 35.2 | 37.9 | 5.88 |
| 2025-07-17 | KRYS | 150.15 | 35.2 | 35.0 | 5.88 |
| 2025-07-18 | KRYS | 147.81 | 35.2 | 31.9 | 5.88 |
| 2025-07-21 | KRYS | 148.10 | 35.2 | 35.7 | 5.88 |
| 2025-07-22 | KRYS | 151.98 | 35.2 | 40.1 | 5.88 |
| 2025-07-23 | KRYS | 153.25 | 35.2 | 36.7 | 5.88 |
| 2025-07-24 | KRYS | 150.00 | 49.4 | 30.8 | 6.11 |
| 2025-07-25 | KRYS | 147.61 | 49.4 | 31.8 | 6.11 |
| 2025-07-28 | KRYS | 153.42 | 53.6 | 42.6 | 6.23 |
| 2025-07-29 | KRYS | 152.08 | 53.6 | 33.8 | 6.23 |
| 2025-07-30 | KRYS | 153.22 | 53.6 | 36.4 | 6.23 |
| 2025-07-31 | KRYS | 153.87 | 53.6 | 35.7 | 6.23 |
| 2025-08-01 | KRYS | 156.98 | 53.6 | 38.8 | 6.23 |
| 2025-08-04 | KRYS | 134.94 | 53.6 | 7.6 | 6.23 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-07 | KRYS | -2.41 | -1.42 | 12.23 |
| 2025-07-08 | KRYS | -2.41 | -1.42 | 12.23 |
| 2025-07-09 | KRYS | -2.41 | -1.42 | 12.23 |
| 2025-07-10 | KRYS | -2.41 | -1.42 | 12.23 |
| 2025-07-11 | KRYS | -3.06 | -1.42 | 12.82 |
| 2025-07-14 | KRYS | -3.06 | -1.33 | 12.82 |
| 2025-07-15 | KRYS | -3.06 | -1.33 | 12.82 |
| 2025-07-16 | KRYS | -3.06 | -1.33 | 12.82 |
| 2025-07-17 | KRYS | -4.65 | -1.33 | 12.83 |
| 2025-07-18 | KRYS | -4.65 | -1.33 | 12.83 |
| 2025-07-21 | KRYS | -4.65 | -1.36 | 12.82 |
| 2025-07-22 | KRYS | -4.68 | -1.36 | 12.82 |
| 2025-07-23 | KRYS | -4.68 | -1.36 | 12.82 |
| 2025-07-24 | KRYS | -4.68 | -1.36 | 12.82 |
| 2025-07-25 | KRYS | -4.70 | -1.36 | 12.66 |
| 2025-07-28 | KRYS | -4.70 | -1.07 | 12.66 |
| 2025-07-29 | KRYS | -4.70 | -1.07 | 12.66 |
| 2025-07-30 | KRYS | -4.70 | -1.07 | 12.66 |
| 2025-07-31 | KRYS | -4.70 | -1.07 | 12.66 |
| 2025-08-01 | KRYS | -4.70 | -1.07 | 12.66 |
| 2025-08-04 | KRYS | -4.70 | -0.05 | 12.66 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.2
Avg. EPS Est. Current Quarter
1.26
Avg. EPS Est. Next Quarter
1.56
Insider Transactions
-4.7
Institutional Transactions
-0.05
Beta
0.66
Average Sales Estimate Current Quarter
95
Average Sales Estimate Next Quarter
101
Fair Value
203.98
Quality Score
87
Growth Score
41
Sentiment Score
94
Actual DrawDown %
38.5
Max Drawdown 5-Year %
-53.4
Target Price
207.36
P/E
27.45
Forward P/E
16.98
PEG
0.47
P/S
10.86
P/B
3.75
P/Free Cash Flow
21.03
EPS
4.92
Average EPS Est. Cur. Y
6.23
EPS Next Y. (Est.)
9.39
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
40.85
Relative Volume
5.68
Return on Equity vs Sector %
-11.3
Return on Equity vs Industry %
7.3
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
0.35
EBIT Estimation
7.6
Krystal Biotech, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 275
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
stock quote shares KRYS – Krystal Biotech, Inc. Stock Price stock today
news today KRYS – Krystal Biotech, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch KRYS – Krystal Biotech, Inc. yahoo finance google finance
stock history KRYS – Krystal Biotech, Inc. invest stock market
stock prices KRYS premarket after hours
ticker KRYS fair value insiders trading